Curia (RNA/Advanced) vs PolyPeptide Group: CDMO Comparison
How does Curia (RNA/Advanced) compare to PolyPeptide Group for Oligo/ASO manufacturing?
Side-by-side comparison of Curia (RNA/Advanced) and PolyPeptide Group on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Curia (RNA/Advanced) holds 18 active EMA GMP certificates; PolyPeptide Group does not appear in EudraGMDP.
On a 13-modality CDMO landscape, both Curia (RNA/Advanced) and PolyPeptide Group qualify as Oligo/ASO manufacturers; Curia (RNA/Advanced) carries the higher composite Signal Score for Oligo/ASO programs in this comparison.
What to evaluate for Oligo/ASO programs
Both Curia (RNA/Advanced) and PolyPeptide Group qualify as Oligo/ASO CDMOs. When choosing between them for Oligo/ASO programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
Synthesis scale
Match synthesizer scale (mmol to mol) to your clinical and commercial demand, and confirm the CDMO can scale without shifting the impurity profile.
Chemistry & conjugation
Confirm experience with your backbone and modifications (phosphorothioate, 2'-MOE/F) and any conjugation (GalNAc, lipid) your molecule requires.
Purity & analytics
Full-length product, deletion/addition impurities, and residual metals drive release. Look for established orthogonal analytics.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.
Frequently asked: Curia (RNA/Advanced) vs PolyPeptide Group
How does Curia (RNA/Advanced) compare to PolyPeptide Group for Oligo/ASO manufacturing?
On CDMO Signal's composite Signal Score, Curia (RNA/Advanced) is 80/100 and PolyPeptide Group is 77/100; Curia (RNA/Advanced) has 2 FDA inspections on record vs 3 for PolyPeptide Group; European coverage is 18 active EMA+MHRA certificates for Curia (RNA/Advanced) vs 0 for PolyPeptide Group. Both are tracked in the CDMO Signal directory as Oligo/ASO CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Curia (RNA/Advanced) or PolyPeptide Group?
Both Curia (RNA/Advanced) and PolyPeptide Group maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Curia (RNA/Advanced) has 2 FDA inspections on record; PolyPeptide Group has 3.
How do Curia (RNA/Advanced) and PolyPeptide Group compare on European GMP coverage?
Curia (RNA/Advanced) holds 18 active EMA GMP certificates and 0 MHRA / UK certificates. PolyPeptide Group holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is better for Oligo/ASO manufacturing — Curia (RNA/Advanced) or PolyPeptide Group?
Both Curia (RNA/Advanced) and PolyPeptide Group are tagged as Oligo/ASO CDMOs in our directory, so both are credible options for Oligo/ASO programs. The most important differentiator for Oligo/ASO selection is typically synthesis scale: Match synthesizer scale (mmol to mol) to your clinical and commercial demand, and confirm the CDMO can scale without shifting the impurity profile. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Curia (RNA/Advanced) carries a Signal Score of 80/100 and PolyPeptide Group carries 77/100 — essentially tied for Curia (RNA/Advanced). The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →